Global Humanized Mouse Model Market By Model Type (Humanized Immune System (HIS) Models, Cell-Line Derived Xenograft (CDX) Models, Genetically Humanized Models (Gene Knock-In/Knock-Out), Humanized Liver Models and Patient-Derived Xenograft (PDX) Models), By Application (Oncology, Gene Therapy & Regenerative Medicine, Infectious Diseases, Inflammatory & Autoimmune Diseases, Metabolic Diseases and Neuroscience), By Species (Mice and Rats), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes and Government & Regulatory Bodies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035